• Oya Güven, Samet Sayılan, Özlem Tataroğlu, Nihat Müjdat Hökenek, and Dilek Vural Keleş.
• Kırklareli University Medical School, Kırklareli Training and Research Hospital, Department of Emergency - Kırklareli, Turkey.
• Rev Assoc Med Bras (1992). 2023 Jan 1; 70 (1): e20230799e20230799.

ObjectiveThis study was designed to determine the effect of cranberry extract used in patients with single urinary tract infections.MethodsPatients with simple-type urinary tract infections were divided into two groups. Treatment with fosfomycin or cranberry tablet was started. On days 1, 3, and 7 of the treatment, whether there was a decrease in the complaints was evaluated with a Likert-type scale. The recovery status of urinary tract infections and the well-being of patients were compared via antibiotic and cranberry groups.ResultsAfter the treatment, the leukocyte levels of the cranberry users were at the same level as those of the other group, and the rate of well-being and the portion of patients that reported to be "very well" on days 3 and 7 in the cranberry group was significantly higher compared with the fosfomycin group (p<0.05).ConclusionConsidering the results of this study, it was determined that the patient's complaints decreased from day 3 and their well-being increased with the use of cranberry only. Specifically, on day 7, the well-being of the cranberry group was higher than that of the fosfomycin group. For this reason, cranberry is a favorable alternative to antibiotics in uncomplicated and simple urinary tract infections.

11 keywords...

hide…